Objective response to sorafenib in advanced clear-cell sarcoma

Ann Oncol. 2012 Mar;23(3):807-809. doi: 10.1093/annonc/mds005. Epub 2012 Jan 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Humans
  • Knee / pathology*
  • Male
  • Niacinamide / analogs & derivatives
  • Oncogene Proteins, Fusion
  • Phenylurea Compounds
  • Pyridines / therapeutic use*
  • Sarcoma, Clear Cell / drug therapy*
  • Sarcoma, Clear Cell / genetics
  • Sorafenib
  • Transcription Factors

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • EWS-ATF1 fusion protein, human
  • Oncogene Proteins, Fusion
  • Phenylurea Compounds
  • Pyridines
  • Transcription Factors
  • Niacinamide
  • Sorafenib